Dr. Ruben Kuruvilla, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: Gulf Coast Veterans Health Care System, 400 Veterans Avenue, Biloxi, MS 39531 Phone: 228-523-4905 |
Philip L Bertucci, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 431 Bertucci Blvd, Biloxi, MS 39531 Phone: 228-385-2020 Fax: 228-388-9435 |
Dr. Anne Elizabeth Baranano, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2781 C T Switzer Sr Dr Ste 100, Biloxi, MS 39531 Phone: 228-207-8632 |
Gregory Emile Bertucci, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 431 Bertucci Blvd, Biloxi, MS 39531 Phone: 228-385-2020 Fax: 228-388-9435 |
Dr. Janet Carriere Harrison, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-4905 |
Joel M Knight, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1720a Medical Park Dr, Suite 330, Biloxi, MS 39532 Phone: 228-396-5185 Fax: 228-396-5186 |
Rainna P Bahadur, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1720a Medical Park Dr, Suite 330, Biloxi, MS 39532 Phone: 228-396-5185 Fax: 228-396-5186 |
Dr. Avit John Gremillion Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 962 Tommy Munro Dr Ste E, Biloxi, MS 39532 Phone: 228-388-7000 Fax: 833-849-9899 |
Dr. Jonathan Edward Ellis, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-0452 |
Dr. Clayton Stevens, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2541 Pass Rd Ste G, Biloxi, MS 39531 Phone: 228-860-7520 |
Dr. Richard Warren Pharr, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1490 West Government Street Suite 8, Richard W Pharr M.d. Pa, Brandon, MS 39042 Phone: 601-825-0287 Fax: 601-825-1091 |
Dr. James Emory Hall, MD, P.A. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1022 D A Biglane Dr, Brookhaven, MS 39601 Phone: 601-833-6363 Fax: 601-833-6364 |
Eugene Ainsworth Simmons Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 624 Highway 51 N, Brookhaven, MS 39601 Phone: 601-823-3098 Fax: 601-823-3099 |
Dr. Tom Cooper, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 561 Medical Dr, Clarksdale, MS 38614 Phone: 662-627-5256 |
Dr. Victor Pang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 561 Medical Drive, Clarksdale, MS 38614 Phone: 662-627-5256 |
Dr. Evelyn Lucile Massey, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 500 Chris Rd, Clarksdale, MS 38614 Phone: 662-645-4545 Fax: 662-358-4407 |
Dr. Harold Lee Peltan, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 425b N Davis Ave, Cleveland, MS 38732 Phone: 662-545-4600 Fax: 662-545-4588 |
Dr. Albert Henlay Laws, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 200 4th Ave S, Columbus, MS 39701 Phone: 662-574-2111 |
Dr. Scott T Bradley, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 425 Hospital Dr, Ste 8, Columbus, MS 39705 Phone: 662-328-2061 Fax: 662-328-5000 |
Dr. William Meek Gillespie Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 425 Hospital Dr, Ste 8, Columbus, MS 39705 Phone: 662-328-2061 Fax: 662-328-5000 |
News Archive
Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today presented updated clinical data from its Phase I/II study of lead product candidate VAL-083 (dianhydrogalactitol), in patients with refractory glioblastoma multiforme (GBM), at GBM2015: 2nd International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain.
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
Tufts Health Plan recently received the prestigious honor of being recognized for its Worksite Wellness initiatives by the Boston Business Journal. As a finalist in the Boston Business Journal's listing of "HEALTHIEST EMPLOYERS," the non profit company was recognized as an organization that is deeply committed to improving the health of its employees and its workplace.
PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced that it has entered into a research and development collaboration with the University of California, San Diego to develop a combination vaccine to prevent genital herpes simplex virus (HSV) infections.
› Verified 3 days ago